Toshiki Kan

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 108 citations · Full text

Medicine, Nephrology, Pharmacotherapy +11

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

Natalie Staplin, Richard Haynes, PK Judge et al. · The Lancet Diabetes & Endocrinology · 2023 · 90 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

PNPLA3 I148M associations with liver carcinogenesis in Japanese chronic hepatitis C patients

Kazunori Nakaoka, Senju Hashimoto, Naoto Kawabe et al. · SpringerPlus · 2015 · 18 citations · Full text

Medicine, Genetics, Molecular Genetics +17

The clinical features of patients with a Y93H variant of hepatitis C virus detected by a PCR invader assay

Toshiki Kan, Senju Hashimoto, Naoto Kawabe et al. · Journal of Gastroenterology · 2015 · 17 citations · Full text

Life Sciences, Molecular Biology, Molecular Genetics +13

Evaluation of a 12-mm diameter covered self-expandable end bare metal stent for malignant biliary obstruction

Kazunori Nakaoka, Senju Hashimoto, Naoto Kawabe et al. · Endoscopy International Open · 2018 · 12 citations · Full text

Medicine, Surgery, Interventional Radiology +14